Jupiter Life Line Hospitals Operational Benchmarking
₹253.95+1.58%close, 9 Oct 2026
- Market cap
- ₹8,325 crore
- P/E
- 22.5
- P/B
- 2.85
- ROE
- 14.5%
- Dividend yield
- 1.20%
- 52-week range
- ₹182.84 – ₹342.83
Jupiter Life Line Hospitals compared with sector peers on revenue, market capitalization, valuation, and return metrics.
Jupiter Life Line Hospitals sector benchmarking & peer comparison
Operational and financial KPI comparison against sector peers.
| Company | LTP (₹) | P/E | Market Cap (₹ cr) | Div Yield | Qtr Sales (₹ cr) | ROCE % |
|---|---|---|---|---|---|---|
| Jupiter Life Line Hospitals Limited | ₹253.95 | 22.5 | 8,325 | 1.2% | 2,081 | 14.5% |
| Median (1 Cos) | ₹253.95 | 22.5 | 8,325 | 1.2% | 2,081 | 14.5% |
Source: NSE sector index filings and financial statements. Data as of 9 October 2026. How this data is compiled.
Same Data For Peers
- Jubilant Pharmova Limited operational benchmarking
- JHS Svendgaard Laboratories Limited operational benchmarking
- Kilitch Drugs (India) Limited operational benchmarking
- Jagsonpal Pharmaceuticals Limited operational benchmarking
- Krishna Institute of Medical Sciences Limited operational benchmarking
- IPCA Laboratories Limited operational benchmarking
Trade Jupiter Life Line Hospitals With ATS
Track JLHL live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.
Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.